Health House International will provide training courses for alternative medicine treatments after securing a deal with Germany’s North-Rhine Association of General Practitioners.
Most commonly the first port of call for accessing healthcare in Germany, GPs are a significant touchpoint for increasing the understanding and confidence in prescriptions of alternative medicines.
Through its subsidiary CanPharma and group company Kalapa Germany, Health House will increase the knowledge base of the over 2500 doctors represented by the organisation as its first alternative medicine collaboration.
The companies said they were all eager to share the knowledge gained through their research and efforts.
“The well-being of the patient has the highest priority which is why we provide patients high-quality; moreover, we feel that this is also achieved by educating healthcare professionals with a solid foundation of knowledge on which to base their future prescriptions of medicinal cannabis,” CanPharma chief executive and Health House executive director Henrik Sprengel said.
“Many doctors in Germany lack experience in using cannabinoids, which is why a broad training is so important. Kalapa is very happy to provide this support so that doctors feel safe in their treatment and educate themselves on the topic of cannabinoids,” Kalapa Germany managing director Gesa Riedewald said.
“We are very pleased that we can share the medical know-how that we have acquired over many years at Kalapa Clinic with the General Practitioners’ Association.
“It has always been our goal to work together with doctors to obtain the best possible and safest therapy for the patients,” Health House chief executive David Attwood said.
HHI’s Australian Stock Exchange-listed price is trading at 8.3c (8:28 am UTC+8 hours)